La description :menu discover fr / en search contact us skip navigation about us company history team scientific council executive board scientific articles our offer our technology therapeutic projects technology pl...
Classement Alexa Global: # 16,725,163
L'adresse IP principale: 176.31.36.160,Votre serveur France,Roubaix
ISP:OVH SAS TLD:com Code postal:fr
Ce rapport est mis à jour en 20-Jul-2018
Created Date:
2008-06-27
Changed Date:
2015-06-24
Données techniques du b-cell-design.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte b-cell-design.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 1, mail exchanger = mx3.ovh.net. MX preference = 5, mail exchanger = mx4.ovh.net. MX preference = 100, mail exchanger = mxb.ovh.net.
HtmlToText
menu discover fr / en search contact us skip navigation about us company history team scientific council executive board scientific articles our offer our technology therapeutic projects technology platform intellectual property partnerships & collaboration scientists funders institutionals accountants and legal advisors investors download mucosal immunity is our vision, infectious diseases, oncology and chronic inflammations our investigation fields, innovation our focus ! b cell design at bio 06/06/2018 09:01 b cell design is attending bio international convention in boston from june 4 to 7. read more b cell design at bio best matwin project in start up category 28/05/2018 15:38 b cell design won the best project prize in the start up category awarded by matwin board! read more best matwin project in start up category arkab is created 10/01/2018 13:41 the company arkab is now created as b cell design's subsidiary! read more arkab is created all news from therapeutic researches to ivd solutions our solutions mucosal immunity b cell design develops a new mucosal immunotherapy approach for generating a large number of drug and vaccine candidates in infectious field and oncology. the innovation is based on a genetically modified mouse model (hamiga) producing chimeric human iga. iga is a class of antibodies particularly involved in the immunity of mucosal area (lung, gut, genital tract, ...) and associated glands (breast, prostate). because of this characteristic, iga is a well-adapted tool to develop innovative treatment for both infectious diseases and mucosal cancer. learn more the antibodies solution arkab, b cell design subsidiarty, offers to in vitro diagnostic companies a reliable, reproducible and secured source of chimeric human antibodies for several purposes: calibrators, positive controls and quality controls for in vitro diagnostic immunoassays to replace human disease state plasma. immunocapture antibodies to replace mice antibodies which triggers false positives or negatives due to hama antibodies. research reagents (development or renewal of diagnostic kits, improvment of the products portfolio…) learn more our expertise b cell design focuses on mucosal immunotherapy which led to develop two groundbreaking drug candidates: a vaccine candidate in infectious diseases field : a worldwide patented hiv vaccine ( a new non-hiv vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against hiv infection – europe patent 14305174.6) to prevent or even cure hiv infections. preliminary studies showed that this approach elicits an efficient local immune response, neutralizing hiv infection of human cells. a drug candidate in oncology field ( colorectal cancer ) for immunotherapy, radioimmunotherapy applications or medical imaging. arkab, b cell design subsidiary, is dedicated to the in vitro diagnostics market. through its patented technology (hamiga tm , gammaprim tm , ineps tm ), arkab develops and manufactures human chimeric antibodies to replace human disease state plasma currently used as calibrators, positive controls and quality controls. 98 rue charles legendre 87000 limoges france +33 5 55 12 30 21 skip navigation sitemap contact us legal notice
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR OVH
SERVERS
SERVER com.whois-servers.net
ARGS domain =b-cell-design.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME b-cell-design.com
CHANGED 2015-06-24
CREATED 2008-06-27
STATUS clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
b-cell-design.com rapport :
Visitez le site